Live Breaking News & Updates on Wyeth Ayerst Global Pharmaceuticals

Stay updated with breaking news from Wyeth ayerst global pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

SCYNEXIS to Present Commercial Launch Update for

SCYNEXIS to Present Commercial Launch Update for
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

University Of California Irvine , United States , Christine Coyne , Vulvovaginal Candidiasis , Marco Taglietti , Eric Francois , Michaell Krychman , Board Of Directors Bionj Inc , Paratek Pharmaceuticals , Head Of Global Research , Southern California Center , Wyeth Ayerst Global Pharmaceuticals , Equity Capital Markets Group At Lazard Ltd , Forest Laboratories Inc , Eastern University , Forest Research Institute , Auxilium Pharmaceuticals , Masters In Public Health , Topi Inc , Stiefel Laboratories Inc , Globe Newswire Scynexis Inc , Sexual Health , Division Of Gynecological Oncology , Marion Merrell Dow Research Institute , Aquestive Therapeutics Inc , Worldwide Clinical Research For Anti ,

SCYNEXIS to Present Commercial Launch Update for BREXAFEMME® (ibrexafungerp tablets)

SCYNEXIS to Present Commercial Launch Update for BREXAFEMME® (ibrexafungerp tablets)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

University Of California Irvine , United States , Christine Coyne , Vulvovaginal Candidiasis , Marco Taglietti , Eric Francois , Michaell Krychman , Relationsgloria Gasaaturalifesci Communicationstel , Relationsirina Kofflerlifesci Advisorstel , Board Of Directors Bionj Inc , Paratek Pharmaceuticals , Southern California Center , Masters In Public Health , Topi Inc , Stiefel Laboratories Inc , Drug Administration , Marion Merrell Dow Research Institute , Aquestive Therapeutics Inc , Exchange Commission , Worldwide Clinical Research For Anti , University Of Pavia , Business Administration , Scynexisscynexis Inc , Rehabilitation Program At Memorial Sloan Kettering Cancer , Head Of Global Research , Wyeth Ayerst Global Pharmaceuticals ,

SCYNEXIS to Present Commercial Launch Update for

SCYNEXIS to Present Commercial Launch Update for
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

University Of California Irvine , United States , Irina Koffler , Christine Coyne , Vulvovaginal Candidiasis , Gloria Gasaatura , Marco Taglietti , Eric Francois , Michaell Krychman , Board Of Directors Bionj Inc , Paratek Pharmaceuticals , Southern California Center , Lifesci Communications , Masters In Public Health , Topi Inc , Stiefel Laboratories Inc , Drug Administration , Marion Merrell Dow Research Institute , Aquestive Therapeutics Inc , Exchange Commission , Worldwide Clinical Research For Anti , University Of Pavia , Business Administration , Rehabilitation Program At Memorial Sloan Kettering Cancer , Head Of Global Research , Wyeth Ayerst Global Pharmaceuticals ,

BioSpace Movers & Shakers, May 14

Published: May 13, 2021
By Alex Keown
Akouos, Inc. – Kathy Reape was named chief development officer of Boston-based Akouos. Reape most recently served as chief medical officer at Spark Therapeutics where she oversaw clinical development, pharmacovigilance, and medical affairs activities. Reape was a key member of the team responsible for the development and commercialization of Luxturna, the first FDA-approved in vivo gene therapy approved for an inherited retinal disease caused by mutations in both copies of the RPE65 gene. Prior to Spark, Reape was senior vice president of clinical development focusing on global brands research and development at Allergan and Actavis.
CARMAT – France-based CARMAT’s board of directors is reorganizing its governance and appointed three new directors. The company tapped Florent Battistella, David Coti and John B. Hernandez as directors. Battistella founded Nisima, a holding company, which holds stakes in various fi ....

United States , Quadrucept Bio , Vineet Agarwal , Janice Olson , Einaro Vik Mo , Kyle Chiang , Penrose Therapeutx , Eli Lilly , Paul Manning , Mann Muhsin , Priteshj Gandhi , Mike Stapley , Annie Partisano , Cokey Nguyen , Stephen Squinto , Carries Cox , Roger Stupp , Andrea Paul , Bristol Myers Squibb , Christine Coyn , Susan Foden , Monika Hegi , Neurocentrx Pharma , Tanya Lewis , Mike Burgess , Jennifer Wheler ,

SCYNEXIS Appoints Accomplished Commercial Executive Christine Coyne as Chief Commercial Officer to Lead the Brexafemme® Launch

SCYNEXIS Appoints Accomplished Commercial Executive Christine Coyne as Chief Commercial Officer to Lead the Brexafemme® Launch
Strengthening the management team with deep anti-infective commercial expertise across hospital and community settings ahead of anticipated approval of Brexafemme (ibrexafungerp) in June 2021 and H2:2021 launch
JERSEY CITY, N.J., May 11, 2021 (GLOBE NEWSWIRE) SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced the appointment of Christine Coyne as Chief Commercial Officer, effective May 10, 2021. Ms. Coyne will play a significant role in the anticipated U.S. launch and commercialization of Brexafemme, the expected trade name for ibrexafungerp, an oral antifungal product candidate for the treatment of vulvovaginal candidiasis (VVC), also known as vaginal yeast infection. The New Drug Application (NDA) for Brexafemme is unde ....

United States , Irina Koffler , Gloria Gasaatura , Marco Taglietti , Paratek Pharmaceuticals , Drug Administration , Scynexis Inc , Wyeth Ayerst Global Pharmaceuticals , Lifesci Communications , Eastern University , Auxilium Pharmaceuticals , Christine Coyne , Chief Commercial Officer , New Drug Application , Prescription Drug User Fee Act , Chief Executive Officer , Senior Vice President , Vice President , Stock Units , Award Plan , Nasdaq Global Market , ஒன்றுபட்டது மாநிலங்களில் , இரினா கோஃப்லர் , கிழக்கு பல்கலைக்கழகம் , துணை மருந்துகள் , கிறிஸ்டின் காய்நெ ,